UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000033371
Receipt No. R000038042
Scientific Title Safety assessment of oral intake of L-Ornithine: Systematic review
Date of disclosure of the study information 2019/04/30
Last modified on 2021/11/21 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Safety assessment of oral intake of L-Ornithine: Systematic review
Acronym Safety assessment of oral intake of L-Ornithine
Scientific Title Safety assessment of oral intake of L-Ornithine: Systematic review
Scientific Title:Acronym Safety assessment of oral intake of L-Ornithine
Region
Japan

Condition
Condition Human who has received L-Ornithine by oral
Classification by specialty
Not applicable
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Investigate the tolerability of orally ingesting of L-ornithine.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes All of adverse events
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria All studies which are intervention of L-Orn oral intake in human.
Key exclusion criteria We exclude studies that is not oral intake of L-Orn or not clinical study.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Kohsuke
Middle name
Last name Hayamizu
Organization Yokohama University of Pharmacy
Division name Laboratory of Food Chemistry
Zip code 245-0066
Address 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
TEL 045-859-1300
Email k.hayamizu@hamayaku.ac.jp

Public contact
Name of contact person
1st name Kohsuke
Middle name
Last name Hayamizu
Organization Yokohama University of Pharmacy
Division name Laboratory of Food Chemistry
Zip code 244-0066
Address 601 Matano-cho, Totsuka-ku, Yokohama, Kanagawa, JAPAN
TEL 045-859-1300
Homepage URL
Email k.hayamizu@hamayaku.ac.jp

Sponsor
Institute Yokohama University of Pharmacy
Institute
Department

Funding Source
Organization International Council on Amino Acid Science
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization meta-analysis
Address meta-analysis
Tel 045-859-1300
Email k.hayamizu@hayamizu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 04 Month 30 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Delay expected
Results Delay Reason It was decided to suspend the project temporarily in order to improve the accuracy of the final results due to the information on the ongoing test regarding L-Orn.
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2018 Year 04 Month 30 Day
Date of IRB
2018 Year 05 Month 10 Day
Anticipated trial start date
2018 Year 07 Month 13 Day
Last follow-up date
2019 Year 10 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Finished web based database search.
Under performing statistical analysis.

Interim analysis report finished

Management information
Registered date
2018 Year 07 Month 12 Day
Last modified on
2021 Year 11 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038042